FDA recall D-0655-2020

Product

Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX

Reason for recall

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Distribution

TX

Key facts

Status

Terminated

Initiation date

2019-12-17

Report date

2020-01-22

Termination date

2021-10-29

Voluntary/Mandated

Voluntary: Firm initiated

Location

Dallas, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0655-2020